Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials

Vaccines are needed to disrupt or prevent continued outbreaks of filoviruses in humans across Western and Central Africa, including outbreaks of Marburg virus (MARV). As part of a filovirus vaccine product development plan, it is important to investigate dose response early in preclinical developmen...

Повний опис

Бібліографічні деталі

Автори:	Christopher L. Cooper, Gavin Morrow, Maoli Yuan, John W. Coleman, Fuxiang Hou, Lucia Reiserova, Shui L. Li, Denise Wagner, Alexei Carpov, Olivia Wallace-Selman, Kristie Valentin, Yesle Choi, Aaron Wilson, Andrew Kilianski, Eddy Sayeed, Krystle N. Agans, Viktoriya Borisevich, Robert W. Cross, Thomas W. Geisbert, Mark B. Feinberg, Swati B. Gupta, Christopher L. Parks
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-09-01
Серія:	Vaccines
Предмети:	vesicular stomatitis virus vaccine vector Marburg virus vaccine emerging infectious disease filoviruses
Онлайн доступ:	https://www.mdpi.com/2076-393X/10/10/1582
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!